Cancer Crosslinks 2026
Thursday, January 22, 2026
at Oslo Cancer Cluster Innovation Park
Bridging innovations to improve clinical outcomes for cancer patients.
Daytime Educational Program: 09:30 Registration, 10:00 - 16:30, includes lunch.
Location: Kaare Norum Auditorium, Ullernchausséen 64, Oslo, Norway (digital option).
Afternoon Networking Event: 18:00 - 19:30
Location: Oslo City Hall, Rådhusplassen 1, 0037 Oslo, Norway
Location: Kaare Norum Auditorium, Ullernchausséen 64, Oslo, Norway (digital option).
Afternoon Networking Event: 18:00 - 19:30
Location: Oslo City Hall, Rådhusplassen 1, 0037 Oslo, Norway
Program
09:30 - 10:00 Registration & Coffee
10:00 - 10:10 Opening
10:10 - 11:50 Session 1 - Mapping complexity: enabling precision cancer medicine through systems biology
Speakers
Taha Merghoub, Professor, PhD, Deputy Director Meyer Cancer Center, Weill Cornell Medicine, New York
Marco Gerlinger, Professor, MD FRCP, Barts Cancer Institute and St Bartholomew's Hospital, London
11:45 - 12:45 Networking Lunch
12:45 - 14:05 Session 2 - From complexity to predictions: integrating computational approaches in cancer care
Speakers
Jana Lipkova, Professor, PhD, University of California, Irvine
Karen Grimes, PhD, University College London Cancer Institute
14:05 - 14:35 Networking break
14:35 - 16:10 Session 3 - Targeting the complexity: translating insights into therapeutic strategies
Speakers
Françoise Kraeber-Bodéré, Professor, MD, PhD, Nantes University
Wolfgang Fendler, Professor, MD, University Hospital Essen
16:10 - 16:20 Closing remarks
18:00 - 19:30 Networking event at Oslo City Hall
Cancer Crosslinks is an educational meeting series which promotes interactions between researchers and clinicians, and encourages translational and clinical research to support collaborations to advance the development of innovative cancer treatments.
Established in 2009 by Oslo Cancer Cluster in collaboration with its member, Bristol Myers Squibb, this yearly meeting has become a leading forum gathering oncologists, hematologists, translational researchers, healthcare providers, regulatory experts, and industry representatives.
The hallmark of Cancer Crosslinks is the educational program featuring international and Norwegian experts presenting recent advances in oncology. The educational program is complemented by tailored activities to stimulate additional interactions and discussions between speakers and representatives from the oncology community.
Established in 2009 by Oslo Cancer Cluster in collaboration with its member, Bristol Myers Squibb, this yearly meeting has become a leading forum gathering oncologists, hematologists, translational researchers, healthcare providers, regulatory experts, and industry representatives.
The hallmark of Cancer Crosslinks is the educational program featuring international and Norwegian experts presenting recent advances in oncology. The educational program is complemented by tailored activities to stimulate additional interactions and discussions between speakers and representatives from the oncology community.
|
Organizer
|
Sponsors 2026
|
|
|
|
To learn more about previous Cancer Crosslinks events, visit the GALLERY.